Mark Mattar
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
- Gastroenterology top 10%
Papers in
- Genetics 18
- Inflammatory Bowel Disease 18
- Epidemiology 17
- Microscopic Colitis 14
- Co-authors
- Aline Charabaty (5 shared papers)Denver Lough (1 shared paper)Michael J. Pishvaian (1 shared paper)Rohan Mandaliya (6 shared papers)Aline Charabaty (4 shared papers)Maham Farshidpour (2 shared papers)Dana Alsaadi (2 shared papers)Nidhi Malhotra (3 shared papers)
- Journals
- The American Journal of Gastroenterology (13 papers)Inflammatory Bowel Diseases (4 papers)Gastroenterology (3 papers)Clinical Colorectal Cancer (1 paper)European Journal of Gastroenterology & Hepatology (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Mark Mattar
32 papers receiving 477 citations
Peers
Comparison fields: 5 of 67
- Oncology 263
- Gastroenterology 42
- Health Informatics 7
- Genetics 113
- Epidemiology 140
Countries citing papers authored by Mark Mattar
This map shows the geographic impact of Mark Mattar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Mattar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Mattar more than expected).
Fields of papers citing papers by Mark Mattar
This network shows the impact of papers produced by Mark Mattar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Mattar. The network helps show where Mark Mattar may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Mattar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 185 | |
| 2 | Current management of inflammatory bowel disease and colorectal cancer. | 2011 | 164 |
| 3 | 2018 | 14 | |
| 4 | 2019 | 14 | |
| 5 | 2018 | 13 | |
| 6 | 2021 | 13 | |
| 7 | 2014 | 11 | |
| 8 | 2021 | 10 | |
| 9 | 2024 | 10 | |
| 10 | 2019 | 6 | |
| 11 | 2017 | 6 | |
| 12 | 2005 | 5 | |
| 13 | 2016 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2018 | 3 | |
| 17 | 2014 | 2 | |
| 18 | Depression and the Aberrant Intestinal Microbiome. | 2024 | 2 |
| 19 | 2024 | 2 | |
| 20 | 2018 | 2 |
About Mark Mattar
Mark Mattar is a scholar working on Genetics, Epidemiology, Oncology, Surgery and Gastroenterology, having authored 44 papers that have together received 486 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (18 papers), Microscopic Colitis (14 papers), Colorectal Cancer Screening and Detection (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Genetic factors in colorectal cancer (3 papers), Gastrointestinal motility and disorders (3 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (263 citations), Gastroenterology (42 citations), Health Informatics (7 citations), Genetics (113 citations) and Epidemiology (140 citations). Mark Mattar has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Aline Charabaty, Denver Lough, Michael J. Pishvaian, Rohan Mandaliya, Aline Charabaty, Maham Farshidpour, Dana Alsaadi, Nidhi Malhotra, Joseph J. Alukal and Madhav Desai. Their work appears in journals such as The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Gastroenterology, Clinical Colorectal Cancer and European Journal of Gastroenterology & Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.